SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

Abstract In order to support vaccine development, and to aid convalescent plasma therapy, it would be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing antibodies (NAbs), and their association with clinical disease severity. Therefore, we used a surrogate viral...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chandima Jeewandara, Deshni Jayathilaka, Laksiri Gomes, Ananda Wijewickrama, Eranga Narangoda, Damayanthi Idampitiya, Dinuka Guruge, Ruwan Wijayamuni, Suranga Manilgama, Graham S. Ogg, Chee Wah Tan, Lin-Fa Wang, Gathsaurie Neelika Malavige
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/55c1ee5b35944f61996ba98978bdc16d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/55c1ee5b35944f61996ba98978bdc16d

Ejemplares similares